| Reorganizations in response to scientific and legislative mandates
continued in the 1990s. For example, the Office of Research Resources created the Division
of Clinical Pharmacology. This Division, consisting of the Chemotherapy and Analytical
Methodology Branch and the Preclinical Development Branch, studied clinical pharmacology
and expanded CDER's interests in clinical investigations. |
|
| In March 1990 HHS Secretary Louis
Sullivan appointed a committee, headed by former FDA Comissioner Charles Edwards, to
review the agency's mission, structure, priorities, staffing, and budget. One
committee member resigned when he was selected by President Bush as the
Commissioner-designate: David Kessler. |
|
